GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Star Equity Holdings Inc (NAS:STRR) » Definitions » ROE %

Star Equity Holdings (Star Equity Holdings) ROE %

: 10.69% (As of Dec. 2023)
View and export this data going back to 2004. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Star Equity Holdings's annualized net income for the quarter that ended in Dec. 2023 was $6.91 Mil. Star Equity Holdings's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $64.65 Mil. Therefore, Star Equity Holdings's annualized ROE % for the quarter that ended in Dec. 2023 was 10.69%.

The historical rank and industry rank for Star Equity Holdings's ROE % or its related term are showing as below:

STRR' s ROE % Range Over the Past 10 Years
Min: -75.8   Med: -2.57   Max: 49.86
Current: 44.9

During the past 13 years, Star Equity Holdings's highest ROE % was 49.86%. The lowest was -75.80%. And the median was -2.57%.

STRR's ROE % is ranked better than
94.5% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -6.24 vs STRR: 44.90

Star Equity Holdings ROE % Historical Data

The historical data trend for Star Equity Holdings's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Equity Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.92 -16.02 -7.88 -13.55 46.95

Star Equity Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.63 4.16 188.10 -16.01 10.69

Competitive Comparison

For the Diagnostics & Research subindustry, Star Equity Holdings's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Equity Holdings ROE % Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Star Equity Holdings's ROE % distribution charts can be found below:

* The bar in red indicates where Star Equity Holdings's ROE % falls into.



Star Equity Holdings ROE % Calculation

Star Equity Holdings's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=25.132/( (41.755+65.299)/ 2 )
=25.132/53.527
=46.95 %

Star Equity Holdings's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=6.912/( (63.994+65.299)/ 2 )
=6.912/64.6465
=10.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Star Equity Holdings  (NAS:STRR) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=6.912/64.6465
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(6.912 / 56.444)*(56.444 / 73.879)*(73.879 / 64.6465)
=Net Margin %*Asset Turnover*Equity Multiplier
=12.25 %*0.764*1.1428
=ROA %*Equity Multiplier
=9.36 %*1.1428
=10.69 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=6.912/64.6465
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (6.912 / 3.844) * (3.844 / -3.204) * (-3.204 / 56.444) * (56.444 / 73.879) * (73.879 / 64.6465)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.7981 * -1.1998 * -5.68 % * 0.764 * 1.1428
=10.69 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Star Equity Holdings ROE % Related Terms

Thank you for viewing the detailed overview of Star Equity Holdings's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Equity Holdings (Star Equity Holdings) Business Description

Traded in Other Exchanges
Address
53 Forest Avenue, Suite 101, Old Greenwich, CT, USA, 06870
Star Equity Holdings Inc is a multi-industry diversified holding company with three segments; Healthcare segment provides products and services in the area of nuclear medicine imaging with a focus on cardiac health. It provides imaging services to healthcare providers using a fleet of solid-state gamma cameras and also the manufacturing, distribution, and maintenance of gamma cameras, The construction segment manufactures modular housing units for commercial and residential applications. It operates in two businesses: modular building manufacturing and structural wall panel and wood foundation manufacturing, including building supply retail operations, and The investments segment generates intercompany revenue from the lease of commercial properties and equipment.
Executives
Thatcher Butcher officer: President - KBS C/O STAR EQUITY HOLDINGS, INC., 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Coleman Richard Kenneth Jr. officer: Chief Operating Officer 53 FOREST AVE, SUITE 101, OLD GREENWICH CT 06870
Ronald A. Schumacher officer: Exec Chairman - EdgeBuilder C/O STAR EQUITY HOLDINGS, INC., 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Jeffrey E. Eberwein director 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Mitchell I Quain director 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
John W Gildea director 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Hannah M. Bible officer: Chief Legal Officer 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Michael A. Cunnion director 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
David James Noble officer: Chief Operating Officer 53 FOREST AVENUE, SUITE 101, OLD GREENWICH CT 06870
Matthew G. Molchan officer: President and CEO 1048 INDUSTRIAL COURT, SUWANEE GA 30024
Cannell Capital Llc 10 percent owner 245 MERIWETHER CIRCLE, ALTA WY 83414
John M Climaco director PO BOX 326, PARK CITY UT 84060
Virgil Lott officer: President, Diagnostic Imaging 1048 INDUSTRIAL COURT, SUWANEE GA 30024
Michael Debeauvernet officer: General Manager,Mobile Imaging C/O DIGIRAD CORPORATION, 1048 INDUSTRIAL COURT, SUWANEE GA 30024
Jeffry R. Keyes officer: Chief Financial Officer 13950 STOWE DRIVE, POWAY CA 92064-8803